Alnylam Pharmaceuticals, Inc. (ALNY) Enters Overbought Territory - Tale of the Tape

By
A A A

Alnylam Pharmaceuticals, Inc. ( ALNY ) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ALNY is now in overbought territory with an RSI value of 86.0 . Furthermore, Alnylam Pharmaceuticals, Inc. currently has a Zacks Rank #4 (Sell) , suggesting that investors may want to consider exiting this stock now before it falls back to Earth.



ALNYLAM PHARMA (ALNY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: ALNY

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

79,812,121
  • $12.11 ▼ 5.61%
68,370,136
  • $104.83 ▲ 1.79%
65,036,978
  • $16.60 ▲ 1.22%
64,087,181
  • $8.40 ▲ 5.93%
54,443,769
  • $33.66 ▼ 2.43%
44,944,529
  • $97.82 ▲ 1.50%
40,119,778
  • $45.02 ▲ 1.44%
34,306,166
  • $80.04 ▲ 2.13%
As of 10/23/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com